| mRNA |
BMS-536924 |
CTRPv2 |
pan-cancer |
AAC |
-0.0043 |
0.9 |
| mRNA |
SNX-2112 |
CTRPv2 |
pan-cancer |
AAC |
0.0038 |
0.9 |
| mRNA |
XMD14-99 |
GDSC1000 |
pan-cancer |
AAC |
0.0039 |
0.9 |
| mRNA |
AZD6244 |
UHNBreast |
pan-cancer |
AAC |
-0.036 |
0.9 |
| mRNA |
pifithrin-mu |
CTRPv2 |
pan-cancer |
AAC |
-0.004 |
0.9 |
| mRNA |
tanespimycin:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0043 |
0.9 |
| mRNA |
navitoclax:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0039 |
0.9 |
| mRNA |
XAV-939 |
GDSC1000 |
pan-cancer |
AAC |
-0.0039 |
0.9 |
| mRNA |
Erlotinib |
UHNBreast |
pan-cancer |
AAC |
0.033 |
0.9 |
| mRNA |
Doxorubicin |
CTRPv2 |
pan-cancer |
AAC |
-0.0033 |
0.9 |